BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome
Conditions: Stroke, Ischemic; Coronary Artery Disease; Angina Pectoris, Stable; Diabetic Peripheral Neuropathy Interventions: Drug: Buqitongluo Granule; Drug: Buqitongluo Granule Placebo; Other: Standard care Sponsors: Dongzhimen Hospital, Beijing; The Affiliated Hospital of Changchun University of Chinese Medicine; The Affiliated Hospital of Shandong University of Chinese Medicine; The Affiliated Hospital of Chengdu University of Chinese Medicine; The Second Affiliated Hospital of Tianjin Univer sity of Traditional Chinese Medicine; The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine; The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine; The Second Affiliated Hospital of Hunan University of Traditional Chines e Medicine; Hunan Academy of Traditional Chinese Medicine Affiliated Hospital; The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine; Shaanxi Buchang Pharmaceuticals Co., Ltd.; Beijing Chuanglikechuang Medical Technology Development Co., Ltd.; Shanghai Youn ingwei Biotechnology Co., Ltd.; Wuhan Zhizhi Medical Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Biotechnology | Brain | China Health | Endocrinology | Hospitals | Ischemic Stroke | Neurology | Research | Stroke